| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Pathology, NCI [E. C. K., W. J., K. A. H., L. A. L.], Bethesda, Maryland, Laboratory of Cell Biology, NIMH, [C. C. E], Bethesda, Maryland, and Department of Biomedical Engineering, Medical College of Virginia, Richmond, Virginia [A. D., R. E]
1 To whom requests for reprints should be addressed, at Laboratory of Pathology, Bldg. 10 Room 2A33, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892.
Evidence is accumulating that calcium homeostasis and calcium-regulated events may be selectively important in generation and maintenance of the malignant phenotype. CAI, a carboxyamido-triazole with a haloge-nated benzophenone tail, is a novel inhibitor of receptor-operated calcium influx and arachidonic acid release which inhibits malignant proliferation, invasion, and metastasis. The focus of this investigation was structural analysis of CAI and to determine if the inhibition of calcium influx and arachidonic acid release by CAI and its antiproliferative activity were mediated through the same chemical domains. Four families of molecular modifications of the CAI parent were synthesized: (I) modification or substitution of the triazole ring; (II) removal of the substituted benzophenone tail; (III) dehalogenation or partial truncation of the benzophenone moiety; and (IV) removal of the triazole and altered substitutions of the benzophenone tail. Compounds were tested for the inhibition of calcium influx and arachidonic acid release and inhibition of proliferation and colony formation in soft agar using the malignant CHO line transfected with the m5 muscarinic receptor and the A2058 human melanoma cell line. Only CAI and Group I compounds inhibited stimulated calcium influx, arachidonic acid release, and proliferation. Linear regression analysis of the relationship of the 50% inhibitory concentration values for all compounds in inhibition of calcium influx and arachidonate release was statistically significant (r2 = 0.993). Similarly, a linear relationship was demonstrated between inhibition of calcium influx and inhibition of tumor cell proliferation (r2 = 0.971). Groups II-IV had minimal or no signal or growth inhibitory activity. This investigation provides the first evidence for a coordinate link between calcium influx, calcium-mediated arachidonic acid release, and malignant proliferation and metastasis and constitutes the initial analysis of structurally important domains of the CAI molecule.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6/ 3/93. Accepted 12/16/93.
This article has been cited by other articles:
|
|
 |
|
  P. R. Chess, M. A. O'Reilly, F. Sachs, and J. N. Finkelstein Reactive oxidant and p42/44 MAP kinase signaling is necessary for mechanical strain-induced proliferation in pulmonary epithelial cells J Appl Physiol, September 1, 2005; 99(3): 1226 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Stadler, G. Rosner, E. Small, D. Hollis, B. Rini, S. D. Zaentz, J. Mahoney, and M. J. Ratain Successful Implementation of the Randomized Discontinuation Trial Design: An Application to the Study of the Putative Antiangiogenic Agent Carboxyaminoimidazole in Renal Cell Carcinoma--CALGB 69901 J. Clin. Oncol., June 1, 2005; 23(16): 3726 - 3732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Winters, A. I. Mehta, E. F. Petricoin III, E. C. Kohn, and L. A. Liotta Supra-additive Growth Inhibition by a Celecoxib Analogue and Carboxyamido-triazole Is Primarily Mediated through Apoptosis Cancer Res., May 1, 2005; 65(9): 3853 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Franklin, T. L. Jetton, C. L. Kuchemann, S. R. Russell, and E. C. Kohn CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3756 - 3766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Hussain, H. Kotz, L. Minasian, A. Premkumar, G. Sarosy, E. Reed, S. Zhai, S. M. Steinberg, M. Raggio, V. K. Oliver, et al. Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer J. Clin. Oncol., December 1, 2003; 21(23): 4356 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Rosner, W. Stadler, and M. J. Ratain Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents J. Clin. Oncol., November 15, 2002; 20(22): 4478 - 4484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Jiang, Q. Zhou, M. K. Yu, L. S. Ho, Z. N. Chen, and H. C. Chan The Involvement of HAb18G/CD147 in Regulation of Store-operated Calcium Entry and Metastasis of Human Hepatoma Cells J. Biol. Chem., December 7, 2001; 276(50): 46870 - 46877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Kohn, E. Reed, G. A. Sarosy, L. Minasian, K. S. Bauer, F. Bostick-Bruton, V. Kulpa, E. Fuse, A. Tompkins, M. Noone, et al. A Phase I Trial of Carboxyamido-triazole and Paclitaxel for Relapsed Solid Tumors: Potential Efficacy of the Combination and Demonstration of Pharmacokinetic Interaction Clin. Cancer Res., June 1, 2001; 7(6): 1600 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Masiero, K. Lapidos, I Ambudkar, and E. Kohn Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx J. Cell Sci., January 10, 1999; 112(19): 3205 - 3213. [Abstract] [PDF]
|
|
|
|
|
|
H. Yasui, W. Butscher, M. Cohen, N. Spriggs, R. Wersto, E. C. Kohn, L. Liotta, and K. Gardner Selective Inhibition of Mitogen-induced Transactivation of the HIV Long Terminal Repeat by Carboxyamidotriazole. CALCIUM INFLUX BLOCKADE REPRESSES HIV-1 TRANSCRIPTIONAL ACTIVATION J. Biol. Chem., November 7, 1997; 272(45): 28762 - 28770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Rodland, R. P. Wersto, S. Hobson, and E. C. Kohn Thapsigargin-Induced Gene Expression in Nonexcitable Cells Is Dependent on Calcium Influx Mol. Endocrinol., March 1, 1997; 11(3): 281 - 291. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Kohn, R. Alessandro, J. Probst, W. Jacobs, E. Brilley, and C. C. Felder Identification and Molecular Characterization of a m5 Muscarinic Receptor in A2058 Human Melanoma Cells. COUPLING TO INHIBITION OF ADENYLYL CYCLASE AND STIMULATION OF PHOSPHOLIPASE A2 J. Biol. Chem., July 19, 1996; 271(29): 17476 - 17484. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
